Metabolic research
Mazdutide
A dual agonist at the glucagon and GLP-1 receptors, studied for appetite signaling and energy expenditure. Freeze-dried, ≥99% pure.
Save up to 30% on Mazdutide.
Stack it with Tirz or Reta to unlock the savings.
20%
+1 peptide
25%
+2 peptides
30%
+3 or more
For research and educational purposes only. PepTalk discusses what researchers study in laboratory settings, not medical advice. Products are sold for laboratory research use only.
The short version
Mazdutide works on two of the body's metabolic signals at once: GLP-1, the appetite-and-fullness signal, and glucagon, a signal tied to burning stored energy. Researchers are interested in it because pairing those two is studied as a way to act on both sides of the energy equation, how much comes in and how much is used.
What researchers are looking at
GLP-1 is a gut hormone released after eating. In the research literature it is studied for slowing how quickly the stomach empties, signaling fullness to the brain, and helping regulate insulin release. GLP-1-based compounds have become one of the most active areas of metabolic research.
Glucagon is usually thought of as the opposite of insulin, since it raises blood sugar. But at the receptor level it is also studied for increasing energy expenditure and mobilizing fat stored in the liver. Mazdutide is built to activate both receptors, so researchers can study appetite effects and energy-use effects together.
That combination is what sets it apart from single-pathway GLP-1 compounds. Mazdutide has been through large human clinical trials, which makes it one of the better-documented compounds in this class, alongside the GIP/GLP and triple-agonist approaches.
The appetite side
Its GLP-1 activity is studied for slowing stomach emptying, signaling fullness and supporting insulin regulation.
The energy side
Its glucagon activity is studied for raising energy expenditure and mobilizing fat stored in the liver.
Both at once
Researchers study how acting on both receptors differs from GLP-1 activity alone.
Where the evidence stands
an honest mapWell characterized in metabolic animal models
Large human clinical trials reported
From the lab toward the clinic
Mazdutide has moved well beyond early research. It has been studied in large, controlled human clinical trials focused on body weight and glucose regulation, which places it among the more thoroughly documented dual-agonist compounds.
At a glance
What it is
A dual receptor agonist
glucagon + GLP-1
Studied for
Appetite and energy use
metabolic research
Class
GCG/GLP dual agonist
like Survo
Research stage
Large human trials
reported
How it arrives
Lyophilized powder
Ships freeze-dried for stability and shelf life. Before research use, it's reconstituted with bacteriostatic water. Once reconstituted, keep it refrigerated and use within the window noted on the Certificate of Analysis.
Bacteriostatic water
Needed to reconstitute
Certificate of analysis
Common questions
GIP/GLP compounds pair GLP-1 with GIP, a pathway studied for insulin response and fat handling. Mazdutide pairs GLP-1 with glucagon instead, which is studied for energy expenditure and liver fat mobilization.
For laboratory and research use only. Sold exclusively for in-vitro research and laboratory experimentation. Not a drug, supplement, or article intended for human or veterinary use; nothing here is medical advice or a claim of therapeutic benefit. Statements describe findings from published research.
Your Reliable Source for High-Quality Research Peptides
FastPeps is more than just a trusted U.S. supplier of research peptides. We are a catalyst for scientific advancement, dedicated to providing the highest quality peptides that empower our clients to push the boundaries of research.
